← Open Payments lookup

MARK BRUDER: Open Payments

NPI 1609864180 · YORK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,046 in 47 payments from 10 companies in 2025. Trend: 2023 $1,356 · 2024 $1,121 · 2025 $1,046

Food & beverage: $1,046
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP11$314
GlaxoSmithKline, LLC.18$310
Amgen Inc.5$136
Novartis Pharmaceuticals Corporation4$88
Regeneron Healthcare Solutions, Inc.3$54
GENZYME CORPORATION2$51
Blueprint Medicines Corporation1$35
Grifols USA, LLC1$29
Genentech USA, Inc.1$16
Organon LLC1$13

Products named: NUCALA, AIRSUPRA, TEZSPIRE, FASENRA, TRELEGY ELLIPTA, DUPIXENT, Rhapsido, AYVAKIT.

Industry payments across PA — which companies pay providers there.